Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.8887
-0.0294 (-3.20%)
At close: Jan 22, 2026, 4:00 PM EST
0.9371
+0.0484 (5.45%)
Pre-market: Jan 23, 2026, 8:00 AM EST

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
3113511418,673
Upgrade
Market Cap Growth
-71.30%218.52%-30.67%-95.78%-99.39%21.62%
Upgrade
Enterprise Value
2729112-
Upgrade
Last Close Price
0.898.1415.90135.0016920.0044764.92
Upgrade
PE Ratio
-----328929.48
Upgrade
PS Ratio
0.382.041.501.9132.284750.02
Upgrade
PB Ratio
2.353.14-5.12-1.19-13.97-2804.46
Upgrade
P/TBV Ratio
2.682.86----
Upgrade
EV/Sales Ratio
0.431.250.853.5531.66-
Upgrade
Debt / Equity Ratio
0.440.09-1.31-1.10-2.11-0.64
Upgrade
Asset Turnover
0.711.250.520.230.428.06
Upgrade
Quick Ratio
0.731.640.370.360.770.03
Upgrade
Current Ratio
1.272.420.690.560.950.05
Upgrade
Return on Equity (ROE)
-294.39%-585.41%----
Upgrade
Return on Assets (ROA)
-109.79%-101.29%-155.91%-135.76%-148.12%-206.67%
Upgrade
Return on Capital Employed (ROCE)
-1261.60%-198.50%1715.20%676.80%30894.50%24.20%
Upgrade
Earnings Yield
-339.91%-75.19%-318.25%-502.55%-25.51%0.00%
Upgrade
Buyback Yield / Dilution
-347.04%-362.24%-1158.33%---
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q